Showing results (1-10 of 1,118) with videos related to
Sort By:
Pageof 112
The British Journal of Cardiology|June 24, 2022
Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategyKieran F Docherty, John J V McMurrayClinical Cardiology|July 5, 2022
Insights into foundational therapies for heart failure with reduced ejection fractionJohn J V McMurray, Kieran F DochertyInternational Journal of Cardiology|June 13, 2018
Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fractionKieran F Docherty, John J V McMurrayKorean Circulation Journal|June 8, 2019
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection FractionPooja Dewan, Kieran F Docherty, John J V McMurrayEuropean Heart Journal|January 13, 2026
Valvular heart failure: evolving pharmacological approachesKieran F Docherty, Catherine M Otto, John J V McMurrayJACC. Heart Failure|October 2, 2020
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HFKieran F Docherty, Muthiah Vaduganathan, Scott D Solomon, et al.European Heart Journal|October 16, 2016
How robust are clinical trials in heart failure?Kieran F Docherty, Ross T Campbell, Pardeep S Jhund, et al.European Heart Journal. Cardiovascular Pharmacotherapy|November 9, 2024
Subcutaneous furosemide in heart failure: a systematic reviewJoanna Osmanska, Mark C Petrie, Kieran F Docherty, et al.Nature Medicine|October 9, 2023
Recent successes in heart failure treatmentCarolyn S P Lam, Kieran F Docherty, Jennifer E Ho, et al.Journal of the American College of Cardiology|September 1, 2024
Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF?Toru Kondo, Alasdair D Henderson, Kieran F Docherty, et al.Pageof 112